The treatment landscape for EGFR-positive non-small cell lung cancer (NSCLC) is changing, and pharmacists are becoming key decision-makers in navigating that complexity. #lungcancer www.pharmacytimes.com/view/more-op... - ThreadSky | a Reddit-style client for Bluesky

alcmi.bsky.social • 36 days ago

The treatment landscape for EGFR-positive non-small cell lung cancer (NSCLC) is changing, and pharmacists are becoming key decision-makers in navigating that complexity. #lungcancer
https://www.pharmacytimes.com/view/more-options-more-questions-how-pharmacists-are-managing-egfr-positive-non-small-cell-lung-cancer

Comments